Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database

BACKGROUND: Tigecycline has broad-spectrum anti-bacterial activity and often used for critically ill patients with complicated infections. Only a few clinical studies have reported the coagulation disorder induced by tigecycline. The aim of this study was to investigate the association between tigec...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Mingxing, Liang, Jinwei, Li, Dandan, Zhao, Ying, Xu, Wanyi, Wang, Lei, Cui, Xiangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898466/
https://www.ncbi.nlm.nih.gov/pubmed/35248072
http://dx.doi.org/10.1186/s12959-022-00369-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898466/
https://www.ncbi.nlm.nih.gov/pubmed/35248072
http://dx.doi.org/10.1186/s12959-022-00369-z

Ejemplares similares